Hemagen regulatory update

Hemagen Diagnostics Inc. (HMGN) HMGN (Waltham, Mass.) received FDA approval to market a clinical test to monitor patients with rheumatic disease by measuring levels of C-Reactive Protein (CRP) in blo...